+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Hybrid Imaging Market (2019-2025)

  • ID: 4987636
  • Report
  • January 2020
  • Region: Europe
  • 112 Pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)

FEATURED COMPANIES

  • Amber Diagnostics, Inc.
  • Atlantis Worldwide, LLC
  • Bruker Corporation
  • Cubersa, Inc.
  • Koninklijke Philips N.V.
  • PerkinElmer, Inc.
The Europe Hybrid Imaging Market is expected to witness market growth of 4.04% CAGR during the forecast period (2019-2025).

The use of hybrid imaging in the diagnosis of diseases across different medical fields, including oncology, cardiology, and neurology, has risen sharply in recent years. This results in a growing demand for qualified professionals to capture and understand the data generated by these tools. Thus, numerous institutes and research centers are undertaking multimodal imaging training programs. In the regional market, Europe obtained a larger share in the market for hybrid imaging. The increasing emphasis on creating multimodal imaging in the region is expected to drive the demand in Europe. The European Society for Hybrid, Molecular and Translational Imaging (ESHIMT) is a non-profit organization established in Europe to encourage and organize the professional activities of people working in the field of hybrid imaging. The organization organizes several educational and training programs for doctors, scientists, physicists, technologists, radiographers, and others in the field.

Western Europe recorded an exponential boost in PET/CT scans in 2018. That being said, the installation statistics of SPECT/CT systems increased gradually as compared to PET/CT installations. Government initiatives to build multimodal or hybrid diagnostic imaging technologies are expected to drive the market. For example, European Cooperation in Science and Technology (COST), a government-funded group that helps in the development of research networks, inaugurated a program called Correlated Multimodal Imaging in Life Sciences (COMULIS).

Based on Application, the market is segmented into Oncology, Ophthalmology, Cardiology, Brain & Neurology, and Other Applications. Based on Type, the market is segmented into PET/CT systems, SPET/CT systems, PET/MR systems, OCT/Fundus Imaging System and Other types. Based on End Use, the market is segmented into Hospitals, Diagnostic Imaging Centers and Other End Use. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Siemens AG (Siemens Healthineers), Canon, Inc. (Canon Medical Systems Corporation), General Electric (GE) Co. (GE Healthcare), Hitachi, Ltd. (Hitachi Healthcare), Koninklijke Philips N.V., PerkinElmer, Inc., Bruker Corporation, Atlantis Worldwide, LLC.

Scope of the Study

Market Segmentation:

By Application
  • Oncology
  • Ophthalmology
  • Cardiology
  • Brain & Neurology
  • Other Applications

By Type
  • PET/CT systems
  • SPET/CT systems
  • PET/MR systems
  • OCT/Fundus Imaging System
  • Other types

By End User
  • Hospitals
  • Diagnostic Imaging Centers
  • Other End Use

By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Companies Profiled
  • Siemens AG (Siemens Healthineers)
  • Canon, Inc. (Canon Medical Systems Corporation)
  • General Electric (GE) Co. (GE Healthcare)
  • Hitachi, Ltd. (Hitachi Healthcare)
  • Koninklijke Philips N.V.
  • PerkinElmer, Inc.
  • Bruker Corporation
  • Atlantis Worldwide, LLC
  • Cubersa, Inc.
  • Amber Diagnostics, Inc.

Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Amber Diagnostics, Inc.
  • Atlantis Worldwide, LLC
  • Bruker Corporation
  • Cubersa, Inc.
  • Koninklijke Philips N.V.
  • PerkinElmer, Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Hybrid Imaging Market, by Application
1.4.2 Europe Hybrid Imaging Market, by Type
1.4.3 Europe Hybrid Imaging Market, by End User
1.4.4 Europe Hybrid Imaging Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2019-Dec - 2015-Jan) Leading Players
3.3.3 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2019-Dec - 2015-Jun) Leading Players
Chapter 4. Europe Hybrid Imaging Market by Application
4.1 Europe Oncology Market by Country
4.2 Europe Ophthalmology Market by Country
4.3 Europe Cardiology Market by Country
4.4 Europe Brain & Neurology Market by Country
4.5 Europe Other Applications Market by Country
Chapter 5. Europe Hybrid Imaging Market by Type
5.1 Europe PET/CT systems Market by Country
5.2 Europe SPET/CT systems Market by Country
5.3 Europe PET/MR systems Market by Country
5.4 Europe OCT/Fundus Imaging System Market by Country
5.5 Europe Other Types Market by Country
Chapter 6. Europe Hybrid Imaging Market by End Use
6.1 Europe Hospitals Market by Country
6.2 Europe Diagnostic Imaging Centers Market by Country
6.3 Europe Other End Use Market by Country
Chapter 7. Europe Hybrid Imaging Market by Country
7.1 Germany Hybrid Imaging Market
7.1.1 Germany Hybrid Imaging Market by Application
7.1.2 Germany Hybrid Imaging Market by Type
7.1.3 Germany Hybrid Imaging Market by End Use
7.2 UK Hybrid Imaging Market
7.2.1 UK Hybrid Imaging Market by Application
7.2.2 UK Hybrid Imaging Market by Type
7.2.3 UK Hybrid Imaging Market by End Use
7.3 France Hybrid Imaging Market
7.3.1 France Hybrid Imaging Market by Application
7.3.2 France Hybrid Imaging Market by Type
7.3.3 France Hybrid Imaging Market by End Use
7.4 Russia Hybrid Imaging Market
7.4.1 Russia Hybrid Imaging Market by Application
7.4.2 Russia Hybrid Imaging Market by Type
7.4.3 Russia Hybrid Imaging Market by End Use
7.5 Spain Hybrid Imaging Market
7.5.1 Spain Hybrid Imaging Market by Application
7.5.2 Spain Hybrid Imaging Market by Type
7.5.3 Spain Hybrid Imaging Market by End Use
7.6 Italy Hybrid Imaging Market
7.6.1 Italy Hybrid Imaging Market by Application
7.6.2 Italy Hybrid Imaging Market by Type
7.6.3 Italy Hybrid Imaging Market by End Use
7.7 Rest of Europe Hybrid Imaging Market
7.7.1 Rest of Europe Hybrid Imaging Market by Application
7.7.2 Rest of Europe Hybrid Imaging Market by Type
7.7.3 Rest of Europe Hybrid Imaging Market by End Use
Chapter 8. Company Profiles
8.1 Siemens AG (Siemens Healthineers)
8.1.1 Company Overview
8.1.1 Financial Analysis
8.1.2 Segmental and Regional Analysis
8.1.3 Research & Development Expense
8.1.4 Recent strategies and developments:
8.1.4.1 Partnerships, Collaborations, and Agreements:
8.1.4.2 Product Launches and Product Expansions:
8.1.5 SWOT Analysis
8.2 Canon, Inc. (Canon Medical Systems Corporation)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Acquisition and Mergers:
8.2.5.3 Product Launches and Product Expansions:
8.2.6 SWOT Analysis
8.3 General Electric (GE) Co. (GE Healthcare)
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.3.6 SWOT Analysis
8.4 Hitachi, Ltd. (Hitachi Healthcare)
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Product Launches and Product Expansions:
8.4.6 SWOT Analysis
8.5 Koninklijke Philips N.V.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.5.5.3 Acquisition and Mergers:
8.5.6 SWOT Analysis
8.6 PerkinElmer, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Research & Development Expense
8.7 Bruker Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Product Launches and Product Expansions:
8.7.5.2 Acquisition and Mergers:
8.8 Atlantis Worldwide, LLC
8.8.1 Company Overview
8.9 Cubersa, Inc.
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Product Launches and Product Expansions:
8.1 Amber Diagnostics, Inc.
8.10.1 Company Overview
Note: Product cover images may vary from those shown
  • Siemens AG (Siemens Healthineers)
  • Canon, Inc. (Canon Medical Systems Corporation)
  • General Electric (GE) Co. (GE Healthcare)
  • Hitachi, Ltd. (Hitachi Healthcare)
  • Koninklijke Philips N.V.
  • PerkinElmer, Inc.
  • Bruker Corporation
  • Atlantis Worldwide, LLC
  • Cubersa, Inc.
  • Amber Diagnostics, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...